While investigating
mouse eye cells, Botond Roska and his team at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, noticed that one type behaved unusually in response to movement.
Not exact matches
Using the gene - editing tool CRISPR - Cas9 to turn off certain genes in a
mouse zygote as well as other new techniques to enrich the pluripotent stem
cells of a rat, the group managed to grow various rat organs (a pancreas, heart, and
eyes) in a
mouse embryo.
To figure out how the
cells find their way from the
eye to their final destination in the brain, Osterhout and her colleagues examined
mice that had been bred to make green fluorescent protein, or GFP.
First she deprived juveniles of vision in one
eye so that the corresponding brain
cells failed to make connections; once the
mice reached maturity, they were put in a water maze that required them to recognize a pattern of fine lines to find a floating platform.
EYE CANDY Researchers grew primitive retinas (one shown, with proteins that collect and transmit light signals in green and red) by embedding
mouse embryonic stem
cells in a gel.
Treating the potentially blinding haze of a scar on the cornea might be as straightforward as growing stem
cells from a tiny biopsy of the patient's undamaged
eye and then placing them on the injury site, according to
mouse model experiments conducted by researchers at the University of Pittsburgh School of Medicine.
In a four - year study conducted on the
mouse model in advanced breast cancer metastasis in the
eye's anterior chamber, Petty and colleagues found that the new nanoparticle not only killed tumor
cells in the
eye, but also extended the survival of experimental
mice bearing 4T1 tumors, a
cell line that is extremely difficult to kill.
NERVE PROTECTORS The glowing
cells in this micrograph of a
mouse's optic nerve help shield electrical signals passing between
eyes and brain.
In normal
mice with working photoreceptors (PR driven), stimulating the retina produces a variety of responses in retinal ganglion
cells, the output of the
eye.
«We used a
mouse model of the KPro to, first of all, identify the inflammatory factors that cause damage to the
eye, and then we also quantified the amount of nerve
cell death in the back of the
eye that mediates the optic neuropathy, and, lastly, we looked at blocking these factors with antibodies,» said Reza Dana, M.D., M.Sc., MPH, Director of the Cornea and Refractive Surgery Service at Massachusetts
Eye and Ear and the Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School.
«Importantly, the investigation also demonstrates that newly generated
cells in the
mouse retina not only look and behave like neurons, they also wire correctly to the existing neural circuitry at the back of the
eye.»
Cells within an injured
mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the
eye's circuitry, new research shows.
The study, published in
Cell Reports, involved giving cancer drugs to
mice and inducing uveitis, an incurable autoimmune
eye condition responsible for 1 in every 10 cases of visual impairment in the UK.
After testing the suppressive efficacy of the PshRNA agent in cultured
cells, they injected it into the
mouse's
eyes.
«Our experiments indicate that after stem
cell treatment,
mouse eyes that initially had corneal defects looked no different than
mouse eyes that had never been damaged,» Dr. Funderburgh said.
But three months after the lumican - deficient
mouse eyes were injected with human adult corneal stem
cells, transparency was restored.
Stem
cells collected from human corneas restore transparency and don't trigger a rejection response when injected into
eyes that are scarred and hazy, according to experiments conducted in
mice by researchers at the University of Pittsburgh School of Medicine.
Importantly, 25 of the 115 transcripts, shared by EFTF - expressing pluripotent
cells and the EF, encode for 15 genes that are both expressed in retinal stem / progenitor
cells and required for normal
eye formation in frogs, fish,
mice, or humans (Figure 1C; Table S1).
The finding is based on studies of
mice with altered levels of the growth factor PDGF in neural stem
cells, which play a key role in the development of the
eye.
With the excitement of a young doctor fresh out of medical school, Morales»
eyes light up when he observes the petri dishes that harvest «celulas madre,» or stem
cells, from
mice.
Having discovered a genetic «key» (called P - TEFb) that is important in both cancer
cell growth and immune
cell differentiation, they tested the drugs on a
mouse model for uveitis, an incurable
eye condition in which the immune system mistakenly attacks healthy tissue leading to inflammation of the uvea (the middle layer of the
eye).
The antibodies listed above in the immunocytochemistry section were also used on
eye sections together with a cocktail of antibodies generated against human - specific markers (HSM) to identify human
cells (the Oka blood group antigen,
mouse TRA -1-85, 1 ∶ 10 (a kind gift from Peter Andrews, University of Sheffield, Sheffield, UK) together with
mouse human nuclear antigen, 1 ∶ 1000, Millipore).